Joshua Kazam is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. Joshua is a co-founder and director of both Allogene Therapeutics. Inc. (ALLO) and Kronos Bio. He is a co-founder and partner of Vida Ventures, LLC, a life science investment firm, and was a co-founder and director of Kite Pharma, Inc., where he served on the Board of Directors from inception until its acquisition by Gilead Sciences, Inc. in 2017. Joshua also serves as a director of several privately held companies including IconOVir, Inc, Hubble Contacts, ByHeart Inc, and Breakthrough Properties, LLC. Joshua is a member of the Wharton School’s Undergraduate Executive Board and serves on the Board of the Desert Flower Foundation. Joshua also serves on the Board of Directors for Citymeals on Wheels. He received his B.S. in Economics from the Wharton School of the University of Pennsylvania.
Register for Updates
Two River 689 Fifth Avenue, 12th Floor New York, New York 10022 212.871.7900
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.